NMC
AYTU icon

NEA Management Company’s AYTU BioPharma AYTU Stock Holding History

NEA Management Company’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11
Closed -$6K – 47
2018
Q3 		$6K Hold
11
– – ﹤0.01% 44
2018
Q2 		$12K Hold
11
– – ﹤0.01% 43
2018
Q1 		$29K Buy
+11
New +$75.7K ﹤0.01% 43

Other funds holding AYTU

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NEA Management Company's AYTU Position: Q4 2018 in Review

NEA Management Company sold out of AYTU BioPharma (AYTU) in Q4 2018, closing a stake of 11 shares — an estimated $6K sold.

NEA Management Company first reported a position in AYTU in Q1 2018 and held it in 3 quarters. The position peaked at $29K in Q1 2018. 10 funds tracked by Wall St. Rank hold AYTU as of Q4 2018.

  • NEA Management Company reported no remaining AYTU BioPharma position as of Q4 2018 after selling out during the quarter.
  • NEA Management Company sold 11 AYTU BioPharma shares in Q4 2018, an estimated $6K.
  • NEA Management Company first reported a position in AYTU BioPharma in Q1 2018 and held it in 3 quarters.
  • NEA Management Company's AYTU BioPharma position peaked at $29K in Q1 2018.
  • 10 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2018.

Based on NEA Management Company's 13F filing for Q4 2018, filed 18 Jan 2019.